As usage of the new weight-loss drug Ozempic increases, will the size of the average appetite fall?

Entrepreneurial foodie sisters and founders of Itsa Bagel Domini and Peaches Kemp told Life and Leadership that while Ozempic has its place, over usage of the drug could have negative consequences for the food industry.

We caught up with foodie entrepreneurial sisters Domini and Peaches Kemp, founders of Itsa Bagel 🥯

They discuss their childhood in The Bahamas, running restaurants with Conrad Gallagher, and surviving the pandemic 🍽️

Listen now 👇

— NewstalkFM (@NewstalkFM) April 6, 2025

“We have a situation now where food companies were initially quite concerned because people’s diminished appetites, what impact that would have on processed foods,” said Domini.

“Of course, what they’re doing now is they’re looking at creating processed food with added fibre and added protein because with Ozempic and so on, there’s usually atrophy.

“There’s muscle wastage and also you’re targeting the indigestibility of these products because we know a lot of people suffer side effects of all sorts of indigestion.

“So, these are the two things that are now being wildly tweaked to supply people who are now on Ozempic.”

Domini said it probably won’t take long before restaurants will be dealing with huge amounts of food waste.

You can listen back here:

Main image: Pen injection of semaglutide named ozempic is a diabetes medicine to improve blood sugar